Sponsor

Hotspot Therapeutics Inc.

United States 50 Milk Street Floor 16th, 02109-5002, United States

About the sponsor

Clinical research is centered on advanced solid tumors, with interest in cancers that have not responded adequately to existing standard of care options.

Advanced cancers
Solid tumor oncology
Refractory malignancies

The sponsor’s oncology activity is focused on treatment settings where disease control remains limited and new therapeutic approaches are needed.

About Specializations

Hotspot Therapeutics Inc. runs clinical trials in conditions such as Neoplasm malignant, among others.

Neoplasm malignant

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Neoplasm malignant

Not recruiting

Registered drugNo placebo

Study of HST-1011 Alone and with Cemiplimab for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cemiplimab
Sponsor:Hotspot Therapeutics Inc.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →